LUNA vs. KRMD

Last updated Apr 2, 2026

Compare and contrast key facts about Luna Innovations Incorporated (LUNA) and Repro Med Systems, Inc. (KRMD).

Performance

LUNA vs. KRMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Luna Innovations Incorporated (LUNA) and Repro Med Systems, Inc. (KRMD). The values are adjusted to include any dividend payments, if applicable.

LUNA vs. KRMD - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
LUNA Luna Innovations Incorporated	3.48%	-46.76%	-67.52%	-24.35%	4.15%	-14.57%	35.53%	117.61%	37.86%	65.31%
KRMD Repro Med Systems, Inc.	-26.51%	50.91%	56.82%	-31.23%	19.00%	-50.17%	-7.81%	295.76%	32.00%	150.00%

Fundamentals

Total Revenue (TTM) LUNA : $116.61M KRMD : $41.13M
Gross Profit (TTM) LUNA : $68.80M KRMD : $25.60M
EBITDA (TTM) LUNA : $7.02M KRMD : -$1.85M

Returns By Period

In the year-to-date period, LUNA achieves a 3.48% return, which is significantly higher than KRMD's -26.51% return. Over the past 10 years, LUNA has underperformed KRMD with an annualized return of 1.07%, while KRMD has yielded a comparatively higher 28.80% annualized return.

LUNA

• 1D: 8.18%
• 1M: -19.05%
• YTD: 3.48%
• 6M: 8.18%
• 1Y: 112.50%
• 3Y*: -45.10%
• 5Y*: -35.70%
• 10Y*: 1.07%

KRMD

• 1D: -1.16%
• 1M: -12.32%
• YTD: -26.51%
• 6M: 12.07%
• 1Y: 70.12%
• 3Y*: 0.39%
• 5Y*: 3.59%
• 10Y*: 28.80%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

LUNA vs. KRMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LUNA

LUNA Risk / Return Rank: 74
LUNA Sharpe Ratio Rank: 63
LUNA Sortino Ratio Rank: 80
LUNA Omega Ratio Rank: 87
LUNA Calmar Ratio Rank: 70
LUNA Martin Ratio Rank: 69

KRMD

KRMD Risk / Return Rank: 76
KRMD Sharpe Ratio Rank: 77
KRMD Sortino Ratio Rank: 80
KRMD Omega Ratio Rank: 73
KRMD Calmar Ratio Rank: 75
KRMD Martin Ratio Rank: 75

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LUNA vs. KRMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Luna Innovations Incorporated (LUNA) and Repro Med Systems, Inc. (KRMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LUNA	KRMD	Difference
Sharpe ratio Return per unit of total volatility	0.63	1.18	-0.55
Sortino ratio Return per unit of downside risk	2.14	2.14	0.00
Omega ratio Gain probability vs. loss probability	1.36	1.24	+0.12
Calmar ratio Return relative to maximum drawdown	1.50	1.92	-0.42
Martin ratio Return relative to average drawdown	3.58	4.71	-1.13
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LUNA vs. KRMD - Sharpe Ratio Comparison

The current LUNA Sharpe Ratio is 0.63, which is lower than the KRMD Sharpe Ratio of 1.18. The chart below compares the historical Sharpe Ratios of LUNA and KRMD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	LUNA	KRMD	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.63	1.18	-0.55
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.33	0.06	-0.39
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.01	0.41	-0.39
Sharpe Ratio (All Time) Calculated using the full available price history	-0.08	0.09	-0.17

Correlation

The correlation between LUNA and KRMD is 0.07, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

LUNA vs. KRMD - Dividend Comparison

Neither LUNA nor KRMD has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

LUNA vs. KRMD - Drawdown Comparison

The maximum LUNA drawdown since its inception was -97.65%, roughly equal to the maximum KRMD drawdown of -97.69%. Use the drawdown chart below to compare losses from any high point for LUNA and KRMD.

Drawdown Indicators

	LUNA	KRMD	Difference
Max Drawdown Largest peak-to-trough decline	-97.65%	-97.69%	+0.04%
Max Drawdown (1Y) Largest decline over 1 year	-50.00%	-35.43%	-14.57%
Max Drawdown (5Y) Largest decline over 5 years	-97.65%	-59.29%	-38.36%
Max Drawdown (10Y) Largest decline over 10 years	-97.65%	-84.30%	-13.35%
Current Drawdown Current decline from peak	-90.70%	-65.62%	-25.08%
Average Drawdown Average peak-to-trough decline	-64.99%	-59.09%	-5.90%
Ulcer Index Depth and duration of drawdowns from previous peaks	20.94%	14.45%	+6.49%

Volatility

LUNA vs. KRMD - Volatility Comparison

Luna Innovations Incorporated (LUNA) has a higher volatility of 21.79% compared to Repro Med Systems, Inc. (KRMD) at 10.19%. This indicates that LUNA's price experiences larger fluctuations and is considered to be riskier than KRMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LUNA	KRMD	Difference
Volatility (1M) Calculated over the trailing 1-month period	21.79%	10.19%	+11.60%
Volatility (6M) Calculated over the trailing 6-month period	78.15%	36.00%	+42.15%
Volatility (1Y) Calculated over the trailing 1-year period	181.35%	59.77%	+121.58%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	107.33%	61.31%	+46.02%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	85.24%	71.07%	+14.17%

Financials